RecallRadar

CPSC recall 26157

Mamisan Pain Relieving Topical Ointment

On 2025-12-18 the CPSC announced a recall of Mamisan Pain Relieving Topical Ointment by Miramarlab, citing the ointment contains lidocaine, which must be in child-resistant packaging, as required by the Poison Prevention Packaging Act. The ointment's packaging is not child-resistant, p….

Read the official CPSC notice

AgencyCPSC
Recall number26157
ClassificationNot classified
Statusunknown
Initiated2025-12-18
Published2025-12-18
Last updated2026-09-13 11:58 UTC
CompanyMiramarlab
DistributionUS

Product

Mamisan Pain Relieving Topical Ointment | This recall involves Mamisan Pain Relieving Topical Ointment jars. The ointment comes in an orange container with a white continuous thread lid and has the Mamisan trademark printed on top of the lid and on the label. The ointment was sold in a 3.52 ounce plastic jar. The wraparound label includes instructions and drug facts. Only jars with UPC code 860006498115 are included in the recall.

Reason

The ointment contains lidocaine, which must be in child-resistant packaging, as required by the Poison Prevention Packaging Act. The ointment's packaging is not child-resistant, posing a risk of serious injury or death from poisoning if the contents are swallowed by young children.

Identifiers

upc860006498115

Status history

No status changes recorded since RecallRadar first saw this recall on 2026-09-13 11:58 UTC. Current status: unknown.

Source

Official record: https://www.cpsc.gov/Recalls/2026/Plantimex-Recalls-Mamisan-Lidocaine-Ointment-Containers-Due-to-Risk-of-Serious-Injury-or-Death-from-Child-Poisoning-Violates-Mandatory-Standard-for-Child-Resistant-Packaging

RecallRadar indexes public recall notices from the FDA, USDA FSIS, and CPSC. The official agency notice is the authoritative source. Always confirm details at the linked source before acting.